Skip to main content

Hereditary Amyloidosis

Rare

Genetic Disorder

Hereditary Amyloidosis is treated with 3 medications in our database, including AMVUTTRA, Onpattro, WAINUA. 3 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Alnylam, AstraZeneca. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hereditary Amyloidosis treatment below.

What help exists for Hereditary Amyloidosis

3

drugs indexed

2

with copay cards

2

with patient assistance

5

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Hereditary Amyloidosis

3 total

🎟 = copay card Β· πŸ’™ = patient assistance program

Prior authorization patterns for Hereditary Amyloidosis drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

Yesβ€”β€”

β€”

Medicare Part D

β€”β€”β€”

Grants for Hereditary Amyloidosis patients

11 total Β· 5 open

Hereditary Amyloidosis is a rare disease β€” more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare β†’